| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keisuke Takanobu, Naoki Hashimoto, Shuhei Ishikawa, Ichiro Kusum. Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. BMJ case reports. vol 15. issue 10. 2022-10-13. PMID:36229076. |
combining these procedures may be an effective option in the treatment of patients with refractory schizophrenia whose neutrophil levels are not sufficient to initiate clozapine. |
2022-10-13 |
2023-08-14 |
Not clear |
| Akanksha Sharma, Shoshana Buckhalter, Dan J Siskind, David Castl. Clozapine shared care: mental health services and GPs working together for better outcomes for people with schizophrenia. The Medical journal of Australia. vol 217 Suppl 7. 2022-10-02. PMID:36183317. |
clozapine shared care: mental health services and gps working together for better outcomes for people with schizophrenia. |
2022-10-02 |
2023-08-14 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Shinichiro Nakajima, Kohei Kitagawa, Masafumi Kodama, Hiroyoshi Takeuch. Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study. International clinical psychopharmacology. 2022-09-27. PMID:36165515. |
longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study. |
2022-09-27 |
2023-08-14 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Shinichiro Nakajima, Kohei Kitagawa, Masafumi Kodama, Hiroyoshi Takeuch. Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study. International clinical psychopharmacology. 2022-09-27. PMID:36165515. |
this retrospective cohort study aimed to investigate the longitudinal changes in clozapine dose over a 5-year period in patients with treatment-resistant schizophrenia (trs). |
2022-09-27 |
2023-08-14 |
Not clear |
| Ping-Tao Tseng, Mu-Hong Chen, Chih-Sung Lian. Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia. World journal of psychiatry. vol 12. issue 8. 2022-09-26. PMID:36158309. |
we read the impressive review article "clozapine resistant schizophrenia: newer avenues of management" with great enthusiasm and appreciation. |
2022-09-26 |
2023-08-14 |
Not clear |
| Ping-Tao Tseng, Mu-Hong Chen, Chih-Sung Lian. Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia. World journal of psychiatry. vol 12. issue 8. 2022-09-26. PMID:36158309. |
the author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant schizophrenia (crs), and optimizing clozapine treatment is a key component. |
2022-09-26 |
2023-08-14 |
Not clear |
| Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell, Marin M Jukic, Marianne Kristiansen Kringen, Ole A Andreassen, Magnus Ingelman-Sundberg, Espen Molde. Impact of NFIB and CYP1A variants on clozapine serum concentration - a retrospective naturalistic cohort study on 526 patients with known smoking habits. Clinical and translational science. 2022-09-24. PMID:36152308. |
the results suggest that preemptive genotyping of nfib and cyp1a may be utilized to guide clozapine dosing and improve clinical outcomes in patients with treatment resistant schizophrenia. |
2022-09-24 |
2023-08-14 |
Not clear |
| Madeleine S A Tan, Preeti Pandey, Rink-Jan Lohman, James R Falconer, Dan J Siskind, Harendra S Parek. Fabrication and Characterization of Clozapine Nanoemulsion Sol-Gel for Intranasal Administration. Molecular pharmaceutics. 2022-09-23. PMID:36149013. |
clozapine is the most effective antipsychotic for treatment-resistant schizophrenia. |
2022-09-23 |
2023-08-14 |
Not clear |
| Fumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, Shiori Honda, Edgardo Torres-Carmona, Wanna Mar, Sakiko Tsugawa, Peter Truong, Eric Plitman, Yoshihiro Noda, Masaru Mimura, Napapon Sailasuta, Mark Mikkelsen, Richard A E Edden, Vincenzo De Luca, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrer. Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy ( Psychiatry and clinical neurosciences. 2022-09-16. PMID:36111425. |
gamma-aminobutyric acid (gaba) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy ( gamma-aminobutyric acid (gaba) is the primary inhibitory neurotransmitter in the central nervous system. |
2022-09-16 |
2023-08-14 |
Not clear |
| Fumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, Shiori Honda, Edgardo Torres-Carmona, Wanna Mar, Sakiko Tsugawa, Peter Truong, Eric Plitman, Yoshihiro Noda, Masaru Mimura, Napapon Sailasuta, Mark Mikkelsen, Richard A E Edden, Vincenzo De Luca, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrer. Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy ( Psychiatry and clinical neurosciences. 2022-09-16. PMID:36111425. |
clozapine, the only approved drug for treatment-resistant schizophrenia (trs), involves the gabaergic system as one of its targets. |
2022-09-16 |
2023-08-14 |
Not clear |
| Yu Zheng, Gideon Meyerowitz-Katz, Sian Bramwell, Rajini Jayaballa, Yolinda Assur, Deepali Vasani, Ramanathan Ganapathy, Glen Maberly, Vlasios Brakoulia. Evaluating the Effectiveness of Joint Specialist Case Conferences in Improving Diabetes Control in Patients With Schizophrenia on Clozapine. The Journal of nervous and mental disease. 2022-09-15. PMID:36108285. |
evaluating the effectiveness of joint specialist case conferences in improving diabetes control in patients with schizophrenia on clozapine. |
2022-09-15 |
2023-08-14 |
Not clear |
| Yu Zheng, Gideon Meyerowitz-Katz, Sian Bramwell, Rajini Jayaballa, Yolinda Assur, Deepali Vasani, Ramanathan Ganapathy, Glen Maberly, Vlasios Brakoulia. Evaluating the Effectiveness of Joint Specialist Case Conferences in Improving Diabetes Control in Patients With Schizophrenia on Clozapine. The Journal of nervous and mental disease. 2022-09-15. PMID:36108285. |
clozapine treatment for schizophrenia is typically long-term and is associated with a high rate of diabetes. |
2022-09-15 |
2023-08-14 |
Not clear |
| Sharad Philip, Ashna Jose, Lidiya Silvester, Avinash Shekhar, Geo George, Midhun Dharan Sudha, Shamnad Najee. Clozapine and Ogilvie syndrome in Schizophrenia: Case report of a successful rechallenge. Asian journal of psychiatry. vol 77. 2022-09-12. PMID:36095882. |
clozapine and ogilvie syndrome in schizophrenia: case report of a successful rechallenge. |
2022-09-12 |
2023-08-14 |
Not clear |
| Maolin Hu, Yan Xia, Xiaofen Zong, John A Sweeney, Jeffrey R Bishop, Yanhui Liao, Gina Giase, Bingshan Li, Leah H Rubin, Yunpeng Wang, Zongchang Li, Ying He, Xiaogang Chen, Chunyu Liu, Chao Chen, Jinsong Tan. Risperidone-induced changes in DNA methylation in peripheral blood from first-episode schizophrenia patients parallel changes in neuroimaging and cognitive phenotypes. Psychiatry research. vol 317. 2022-09-08. PMID:36075150. |
as a biomarker for the susceptibility of schizophrenia and clozapine treatment response, dna methylation (dnam) has been studied, but the impact of antipsychotics on dnam has not been explored in drug-naïve patients. |
2022-09-08 |
2023-08-14 |
Not clear |
| Tomás Teodoro, Violeta Nogueira, Joana Aldeias, Marina Teles Martins, José Salgad. Clozapine Associated Periorbital Edema in First Episode Psychosis: A Case Report of a Rare Adverse Effect in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. 2022-09-06. PMID:36066404. |
clozapine associated periorbital edema in first episode psychosis: a case report of a rare adverse effect in treatment-resistant schizophrenia. |
2022-09-06 |
2023-08-14 |
Not clear |
| Juliette Lagreula, Philippe de Timary, Laure Elens, Olivia Dalleu. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation. Therapeutic advances in psychopharmacology. vol 12. 2022-09-02. PMID:36051501. |
antipsychotic polypharmacy (app) prescribing and clozapine underuse are considered inappropriate prescribing in schizophrenia. |
2022-09-02 |
2023-08-14 |
Not clear |
| Aya Torii-Goto, Akira Yoshimi, Yuko Tashiro, Mako Ukigai, Aoi Matsumoto, Norio Ozaki, Yukihiro Nod. A Reactive Metabolite of Clozapine Induces Hematopoietic Toxicity in HL-60 Cells Undergoing Granulocytic Differentiation through Its Effect on Glutathione Metabolism. Biological & pharmaceutical bulletin. vol 45. issue 9. 2022-09-01. PMID:36047190. |
clozapine is an atypical antipsychotic with several advantages over conventional antipsychotics, in addition to its well-known efficacy in treatment-resistant schizophrenia. |
2022-09-01 |
2023-08-14 |
Not clear |
| Hannah St Francis, Madeline H Renny, Rana Biary, Mary Ann Howland, Mark K S. Clozapine Toxicity in Two Young Siblings Due to a Pharmacy Dispensing Error: a Pediatric Case Report. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2022-08-26. PMID:36018467. |
clozapine is an atypical antipsychotic used to treat refractory schizophrenia; in both therapeutic use and overdose, it can cause significant toxicity. |
2022-08-26 |
2023-08-14 |
Not clear |
| Kotaro Sugita, Yasuhiro Mori, Kousuke Kanemoto, Sotaro Sugit. Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count. Science progress. vol 105. issue 3. 2022-08-24. PMID:36000301. |
long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ect stabilizes white blood cell count. |
2022-08-24 |
2023-08-14 |
Not clear |
| Kotaro Sugita, Yasuhiro Mori, Kousuke Kanemoto, Sotaro Sugit. Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count. Science progress. vol 105. issue 3. 2022-08-24. PMID:36000301. |
the present study was conducted to investigate the possible hematologic impact of long-term electroconvulsive therapy (ect) in patients with drug-resistant schizophrenia and receiving clozapine therapy. |
2022-08-24 |
2023-08-14 |
Not clear |